文献速递心力衰竭与心肌病

肥厚型心肌病:疾病特异性红旗征的患病率

Hypertrophic cardiomyopathy: prevalence of disease-specific red flags.
PubMed 文献 · Eur Heart J · 2025-01-01

该研究纳入欧洲四中心818例临床诊断肥厚型心肌病患者,系统评估五大领域预设红旗征。共识别2979个红旗征,34%可经病史和体格检查(全科场景)发现,66%需心电图和超声心动图(心内科场景)识别;非肌节病因以非心脏红旗征为主,肌节性HCM以心脏红旗征为主。

要点

  • 肥厚型心肌病患者中红旗征常见,非肌节病因以非心脏红旗征为主,肌节性HCM以心脏红旗征为主。
  • 34%红旗征可仅通过临床病史和体格检查在全科场景发现,对识别罕见HCM表型意义重大。
  • 物理检查红旗征几乎仅见于明确非肌节病因患者(348/350,99%)。

核心结论

  • 红旗征在肥厚型心肌病患者中普遍存在,非肌节病因以非心脏红旗征为主,肌节性HCM以心脏红旗征为主。
  • 超过34%的红旗征(多与罕见HCM表型相关)可在全科场景中潜在检出。

研究设计与样本

  • 研究队列包括818例临床诊断肥厚型心肌病患者,其中男性479例(62%),平均年龄49±21岁,转诊至四个欧洲中心。
  • 预设红旗征分为五个领域:家族史、体格检查、心电图、超声心动图和实验室检查。

主要发现

  • 318例(39%)患者携带致病或可能致病肌节基因变异;240例(29%)携带TTR和GLA变异;154例(19%)为综合征病因;106例(13%)无可识别病因。
  • 共识别2979个红旗征,其中1018个(34%)可仅通过临床病史和体格检查(全科场景)识别,1961个(66%)需通过12导联心电图和超声心动图(心内科诊室)识别。
  • 非肌节病因患者更多在<20岁和>60岁诊断(476/500,95%)。
  • 综合征疾病如Rasopathies、遗传代谢病和线粒体病在新生儿/幼儿期诊断(平均年龄3±2岁),而Danon病、Friedreich共济失调、Noonan综合征和PRKAG2心肌病多在青春期识别(平均年龄16±8岁)。
  • 由临床病史、体格检查和常规实验室检查识别的非心脏红旗征在Rasopathies、遗传代谢病和线粒体病所致HCM患者中最常见(分别为48%、47%和57%)。

临床怎么用

  • 临床应系统搜索HCM相关红旗征,结合病史、体格检查、心电图和超声心动图等多维度评估。
  • 在全科场景中提高对HCM相关红旗征的认识,有助于提高诊断率并合理利用资源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The European Society of Cardiology guidelines recommend a systematic search for diagnostic clues or 'red flags' (RFs) in patients with hypertrophic cardiomyopathy (HCM) to better tailor disease management. To date, the prevalence and clinical significance of RF associated with HCM phenotypes in different clinical settings are unknown. METHODS: The study cohort comprised 818 patients with a clinical diagnosis of HCM [479 (62%) males, mean age 49 ± 21 years] referred to four European centres. Pre-specified RFs were categorized into one of five domains: (i) family history; (ii) physical examination; (iii) electrocardiography; (iv) echocardiography; and (v) laboratory. RESULTS: A total of 318 (39%) patients had a pathogenic or likely pathogenic sarcomere gene variant; 240 (29%) a TTR and GLA variant; 154 (19%) a syndromic cause; and 106 (13%) no identifiable cause. In the overall cohort, 2979 RFs were identified. Of these, 1018 (34%) were identifiable from clinical history and examination alone (generalist setting) and 1961 (66%) by 12-lead electrocardiogram and echocardiography (cardiologist's office). Non-sarcomeric patients were diagnosed more often aged <20 and after 60 years (476/500, 95%). Syndromic diseases such as Rasopathies, inherited metabolic disorders, and mitochondrial disorders were diagnosed in neonatal/early childhood (mean age 3 ± 2 years), whereas patients with Danon disease, Friedreich's ataxia, Noonan syndrome, and PRKAG2 cardiomyopathy were identified mostly during adolescence (mean age 16 ± 8 years). Non-cardiac RFs identified by clinical history, physical examination, and routine laboratory testing were most frequent in patients with HCM caused by Rasopathies, inherited metabolic disorders, and mitochondrial disorders (48%, 47%, and 57%, respectively). Physical RFs were almost exclusively observed in patients with a definite non-sarcomeric aetiology [348/350 (99%)]. On the contrary, most RFs associated with geno-positive and geno-negative HCM were derived from electrocardiogram and echocardiography [692/990 (70%) and 332/375 (88%), respectively]. CONCLUSIONS: Red flags are a common finding in patients presenting with HCM, most commonly non-cardiac in non-sarcomeric aetiology and cardiac in sarcomeric HCM. Over 34% of RF, most relevant to rare HCM phenocopies, can be potentially detected in a generalist setting. Investing in high-touch-low tech, widespread awareness for HCM-related RF may provide substantial advantage in terms of diagnostic yield and appropriate use of resources.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Maurizi N, Monda E, Biagini E, et al. Hypertrophic cardiomyopathy: prevalence of disease-specific red flags. Eur Heart J. 2025. PMID: 39928417. doi:10.1093/eurheartj/ehaf026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。